Meta Plans Massive AI Infrastructure Investment Spending to Reach 65 Billion Xunlei XNET Reports Q3 2024 Results EPS 008 Meets Consensus Mortgage Rates Stall at 636 as Home Inventory ImprovesBut Buyers Face New Hurdles Long Island Rail Road Strike Enters Third Day as Labor Talks Resume LongTerm Investment Focus Examining the Case for 20Year Stock Holdings Inflation Expected to Reach 6 in Q2 According to Latest Economic Survey Page Industries Reports Strong Top Line Growth as Revenue from Operations and Sales Volume Increase Medantas Growth Strategy Established Hospitals Anchor NearTerm Performance Expansion Plans Underway Stock Market Rises on USIran Peace Hopes Snowflake Reaches YeartoDate High A Family Dilemma Timing the CashOut of Inherited CDs During Hospice Care LB Foster Q1 2026 Earnings Strong EPS Surprise Despite Revenue Uncertainty Kadant Inc Q1 2026 Earnings EPS Surges 347 Above Consensus Estimates SOBR Q3 2025 Earnings Negative EPS Reported No Revenue Disclosed CBUS Q1 2026 Earnings Narrower Loss Beats Estimates as Shares Climb Scholastic Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline ENVA Q1 2026 Earnings EPS Beats Estimates Stock Rises 139 Algorhythm Holdings RIME Rallies 395 to 076 Testing Key Resistance Zone Capital Clean Energy Carriers CCEC Posts Modest Gain Approaches Key Resistance Duke Energy Preferred DUKB Edges Higher Holding Above Key Support Level Ocugen Inc OCGN Rallies 3 as Biotech Stock Tests Key Resistance Near 145 Manhattan Bridge Capital LOAN Slips 118 Amid Consolidation Near Support Singapore Gains from AI Investment Boom but Faces Chip Supply Risks MTI Warns Jim Cramer Discusses NVIDIAs Recent Quarterly Performance Casella Waste Systems Shares Dip Despite Strong Quarterly Performance Market Rally Highlights Portfolio Winners and Laggards Over Recent Six Weeks Adani Enterprises Among Stocks Reaching 52Week Highs as Market Momentum Builds Trumps Approval Rating Remains Below 39 in Latest Polls With More Declines Than Gains First Mid Bancshares FMBH Q1 2026 Earnings EPS Surpasses Expectations by 531 Amid Steady Performance Oramed Pharmaceuticals ORMP Drops 89 Support Level Under Pressure